Back to Journals » Journal of Hepatocellular Carcinoma » Volume 2

Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Total article views   Abstract views HTML views PDF downloads Totals
6,474 Dovepress* 4,770 1,449+ 684 6,219
PubMed Central* 0 255 32 255
Totals 4,770 1,704 716 6,474
*Since 22 June 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar